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Length of stay (LOS) for hospitalized patients is an important metric used by institutions to decrease hospital cost and manage capacity. In most patient populations, increased LOS is thought to incur higher hospital costs and decreased profitability, although evidence supporting this is scant. 1 LOS is commonly used to quantify hospital performance, and so lowering LOS is often emphasized as it is believed to be correlated with improved cost containment. 2, 3 Whether lowered LOS actually results in hospital savings is unclear. 4 A study showed that reducing the LOS by as much as an entire day reduced the total cost of care by only 3%. 5 Invasive electrode monitoring is utilized when noninvasive studies (e.g., high-resolution magnetic resonance imaging [MRI] , positron-emission testing, magnetoencephalography [PET] , and single-photon emission computed tomography [SPECT] ) cannot adequately localize the ictal-onset zone in patients with medically refractory focal epilepsy. 6 The two main modalities for invasive monitoring are subdural grid (SDG) and stereoelectroencephalography (SEEG). Epilepsy centers commonly utilize a multispecialty epilepsy management conference to evaluate each patient and tailor the invasive electrode study of choice with the patient's clinical presentation.
Regardless of which invasive electrode strategy is employed, an adequate number and type of seizures are required to be captured to localize the ictal-onset zone. Although the average implantation time with subdural grid implantation is approximately 1 week, this may vary greatly based on implantation effects and recent anesthesia administration. 6, 7 Patients undergoing invasive electrode monitoring may require a longer length of stay because intracranial recording is predicated on obtaining enough seizures to appropriately localize the ictal-onset zone, and the time frame to obtain these data is often unpredictable.
We examined the economic impact of increased LOS on institutional profit and contribution margin in patients undergoing intracranial monitoring and hypothesized that increasing LOS has a negative effect on these economic factors.
Methods
We retrospectively analyzed monthly data for patients with epilepsy undergoing intracranial electrode monitoring for ictal-onset zone localization between August 2014 and June 2016. Data were collected directly from the University of California, Irvine financial database and indicate expected payments from each insurance provider based on type of surgery performed. Seventy-six patients underwent invasive electrode monitoring, either SDG or SEEG, during this 2-year time frame. Costs per patient, as well as profit and contribution margin, were obtained directly from the hospital accounting systems, and patient information was obtained from the medical records.
Implantation protocol
All patients with medically refractory focal epilepsy were discussed in our epilepsy management conference, and those that were deemed good candidates were admitted for invasive electrode monitoring. All surgeries were performed by two surgeons (SV or FPKH).
At our institution, patients undergo subdural grid implantation and then are admitted directly to the epilepsy monitoring unit for seizure monitoring. For typical sampling in uncomplicated patients with low pre-test probability for multifocal onset, a minimum of five seizures was obtained for each patient undergoing invasive monitoring. If the suspicion of bilateral or multifocal onset is high, a minimum of 10 seizures was obtained. This has been supported in the literature using scalp EEG. 8 Once data collection is complete and ictal onset is localized, the patient is taken back to the operating room (OR) for grid removal and concomitant therapeutic surgery (e.g., resection, laser ablation, responsive neurostimulation).
Conversely, SEEG implantation is followed by explanation after ictal-onset localization. Patients are discharged home and then return within 2 weeks for definitive therapeutic surgery.
At our institution, one of the surgeons (SV) did not utilize the intensive care unit (ICU) for postoperative care for invasive patients (i.e., patients admit directly to the epilepsy monitoring unit [EMU]), which was a surgeon preference.
Data
Raw data were obtained directly from the financial department, and expected charges per patient were collected so that an "apples-to-apples" comparison could be performed. Data points collected included the following: 1, insurance type for each patient; 2, type of invasive electrode monitoring performed; 3, LOS; 4, profit margins per patient (i.e., the difference between revenue generated by sales and the cost of business); 5, contribution margins per patient (i.e., the incremental profit earned for each patient); 6, number of subsequent therapeutic surgeries performed; and 7, complications incurred. We excluded monthly data where no patients underwent intracranial monitoring. The University of California, Irvine Institutional Review Board has approved this study.
Statistical analysis
We looked for correlations between LOS and profit margins per patient as well as LOS and contribution margins per patient. We calculated correlation coefficients, coefficients of determination, and p-values for both. We also used a chisquare test to investigate differences in SEEG/SDG and whether insurances were evenly distributed. Means and standard deviations are provided. Wizard Pro (version 1.8.16 ) was used to analyze the data and create Figure 1 .
Results
The results are summarized in Tables 1 and 2 For complications, there were the following: 1, a small intracerebral hematoma with SEEG found on routine computed tomography (CT); and 2, two subdural fluid collections with SDG that required grid revision. There was no morbidity or mortality in this population. One patient had a deep vein thrombosis during implantation that required long-term anticoagulation. None of these patients required additional surgeries; the only additional costs were 1-2 surveillance CT scans. All patients had localization of ictalonset zone and underwent subsequent therapeutic intervention except for two patients undergoing SEEG. These patients were offered vagus nerve stimulation.
Discussion
Patients undergoing intracranial electrode monitoring for epilepsy must have an adequate number and type of seizure to localize the ictal-onset zone and proceed with further treatment options such as resection or neurostimulation. Although several methods are utilized to attempt to induce seizures, including strobe lights and sleep deprivation, 9 seizure frequency may decrease immediately after surgery because of anesthesia and implantation effects. 7 These patients must remain in the hospital until enough seizures are captured to localize the ictal-onset zone, and this can often lead to longer LOS. LOS is an important metric to assess bed management and hospital discharge flow, but patients undergoing intracranial monitoring often have extended LOS due to the preceding factors. Our study analyzed the effects of increased LOS on two other important hospital metrics, namely profit and contribution margin.
Although correlation is not causation, this study found that increased LOS for patients undergoing intracranial electrode monitoring was associated with higher profit and contribution margins per case. This would be of financial concern if longer LOS resulted in hospital losses, but this study suggests that the hospital realized increased financial gain from these patients in the setting of increased LOS.
These cases may maintain profit for a variety of reasons. These patients are typically healthy aside from epilepsy disorder and require few inpatient labs and imaging studies, thereby reducing additional costs associated with higher care intensive patients in the neurologic ICU. These patients also require multiple-staged surgeries, which are generally more profitable to hospitals than inpatient video-EEG (vEEG studies). The main cost disadvantage is that these patients occupy rooms that could be used for other vEEG monitoring, but the literature suggests that only 23% of patients undergoing vEEG eventually are considered surgical candidates. 10 The profit and contribution margins were also affected by the patient's insurance provider. Certain insurance providers such as Medi-Cal (California Medicaid) and Medicare offer a bundled payment based on the patient's diagnosisrelated group (DRG), whereas private insurance may also include an additional payment for each day the patient is admitted in the hospital. Although some of the profit and contribution margin may be attributed to private insurance providers, these patients were a relatively small percentage The complication rates were in-line with the literature and included one focal hematoma associated with SEEG implantation and two subdural collections associated with SDG implantation. The subdural collections required early evacuation and grid revision. None of these complications caused long-term neurologic compromise or sequelae, and there were no deaths associated with this group.
Our study has potential limitations. First, the study may not be generalizable to other institutions because the insurance mix could be different and we were unable to analyze the data specifically by insurance type. Nevertheless, our payor mix was very diverse, but we were still able to show increased profit, which is a good indication that these findings likely translate to other institutions (e.g., payor mix alone did not explain our findings). This study suggests that across a wide variety of insurance types, increased LOS is associated with an increase in profit and contribution margin. Second, patients undergoing SDG likely had a slightly greater LOS than patients undergoing SEEG; the decision to use SDG over SEEG was based on clinical indications, which means our results were based on appropriate clinical indications for each patient rather than costs provisions. Our decision process and case mix were consistent with the standard of care and with those of other institutions 11 ; thus, that did not affect our results.
Hospitals must be efficient and manage capacity, and decreasing the LOS is considered one possible mechanism to accomplish this. Our data show that in patients undergoing invasive monitoring, higher LOS may not necessarily be associated with lowered or negative financial gain in the absolute, and that the converse may be true. Analyzing LOS for cost-containment should not be conflated. Each specialty service is associated with an LOS that likely has its own unique financial implications and should be investigated separately.
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